Keefe K S, Freeman W R, Peterson T J, Wiley C A, Crapotta J, Quiceno J I, Listhaus A D
Department of Ophthalmology, United States Navy Hospital, San Diego.
Ophthalmology. 1992 Sep;99(9):1377-84. doi: 10.1016/s0161-6420(92)31804-4.
To analyze a phenomenon seen in patients with acquired immune deficiency syndrome (AIDS) with cytomegalovirus (CMV) retinitis undergoing systemic antiviral treatment: a persistent white border opacification on the edge of healed CMV retinitis.
The authors prospectively evaluated a population of 137 patients with AIDS and CMV retinitis during a 44-month period. Eleven patients (12 eyes) who were undergoing maintenance antiviral treatment were identified with an atypical healing response--the persistence of a white flat border opacification that did not advance for many weeks to months. Patient records and photographs were reviewed. Results of one autopsy were analyzed with histopathology and special stains.
The persistent white edge maintained (without advancement or smoldering) for an average of 11.6 weeks (range, 4 to 41 weeks). This border opacification was not affected by reinduction treatment in the six patients to whom reinduction was given. Results from histopathologic examination of one patient with a persistent white border are presented: these results show that dead cytomegalic cells formed stable structures within the retina, causing white opacification that could be confused with active lesions. Immunoperoxidase stains identified CMV antigens.
This persistent white border opacification, which does not advance or smolder, represents an important clinical entity that should be recognized during antiviral treatment for CMV retinitis. It can often be observed. If it is not recognized as a stable configuration, patients may undergo unnecessary reinductions with potentially toxic doses of antiviral medications.
分析接受全身抗病毒治疗的获得性免疫缺陷综合征(AIDS)合并巨细胞病毒(CMV)视网膜炎患者中出现的一种现象:愈合的CMV视网膜炎边缘持续存在白色边界混浊。
作者在44个月期间对137例AIDS合并CMV视网膜炎患者进行了前瞻性评估。11例(12只眼)正在接受维持性抗病毒治疗的患者被发现有非典型愈合反应——白色扁平边界混浊持续存在,数周甚至数月都无进展。回顾了患者记录和照片。对1例尸检结果进行了组织病理学和特殊染色分析。
白色边缘持续存在(无进展或缓慢进展),平均持续11.6周(范围为4至41周)。在接受再诱导治疗的6例患者中,这种边界混浊不受再诱导治疗的影响。展示了1例白色边界持续存在患者的组织病理学检查结果:这些结果表明,死亡的巨细胞在视网膜内形成了稳定结构,导致白色混浊,可能会与活动性病变混淆。免疫过氧化物酶染色鉴定出CMV抗原。
这种不进展或缓慢进展的持续白色边界混浊是一种重要的临床现象,在CMV视网膜炎抗病毒治疗期间应予以识别。它经常可以观察到。如果不将其识别为稳定状态,患者可能会接受不必要的、使用潜在毒性剂量抗病毒药物的再诱导治疗。